Recombinant Anti-human FOLR1 Intrabody [Tat]
Recombinant anti-FOLR1 intrabody in fusion with HIV Tat works within cells to bind FOLR1, which is selectively overexpressed in 90% of nonmucinous ovarian carcinomas, expressed in CHO cells. FR expression is associated with tumor progression and affects cell proliferation and the intracellular expression of single-chain (sc) antibodiess (intrabody) can downmodulate membrane expression of FR in ovary cancer cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | IAB-B029(T) |
| Pricing | Inquiry |
| Host | mouse |
| Target | FOLR1 |
| Species Reactivity | human |
| Type | scFv-Tat |
| Applications | Antibody assay: Western blot; Immunocytochemistry; Neutralization; Functional studies |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |